Syllabus:GS2/Health; GS3/Economy
In News
- India’s medical devices market is projected to grow steadily from US$ 15.2 billion in 2025 to US$ 50.1 billion by 2030.
Medical devices industry in India
- The medical devices industry comprises diagnostic imaging, consumables, implants, surgical instruments, in-vitro diagnostics (IVD), patient monitoring systems, orthopaedic devices, cardiovascular devices, and home healthcare products.
- These segments support India’s expanding healthcare ecosystem.
Present Status
- India’s healthcare and medical technology (MedTech) sector is recognised as a sunrise sector with immense growth potential.
- The size of the Indian medical devices sector is estimated to be around $14 billion and it is expected to grow to $30 billion by 2030.
- India is the fourth largest medical devices market in Asia after Japan, China, and South Korea and among the top 20 global medical devices markets in the world.
- India’s medical devices exports have also crossed the $4-billion mark, positioning the country as a global leader in the MedTech manufacturing sector.
Factors Driving India’s MedTech growth
- Technology Adoption and Infrastructure Building: The fast growth of hospitals, diagnostic centers, wearables and advanced diagnostics is leading to broad use of medical tech across the country.
- Demand for healthcare: Rising disposable income, greater health awareness and more individual expenditure are widening access and expanding the home market.
- Skilled Manufacturing at Low Cost: India enjoys huge cost advantages and a highly skilled workforce, an edge it showed in its fast response manufacturing during the COVID-19 epidemic.
- Dynamic Startup Ecosystem: Over 250 MedTech businesses are driving innovation to develop accessible, localised healthcare solutions.
- Digital Connectivity: High mobile phone penetration and enhanced internet infrastructure are speeding up the use of digital health platforms and MedTech solutions.
- Medical Tourism Market: India’s desire for next-generation medical technologies is robust, with 2.36 million overseas patients visiting the country from 210 countries between 2019 and 2024.
- Strategic Policies & Investments: Long-term sector growth is driven by government programs including Production Linked Incentive (PLI) schemes, venture capital funding and booming export activity.
Significance
- Increasing Demand for Healthcare: Rapid urbanisation, an ageing population and the rising prevalence of non-communicable diseases (NCDs) such as diabetes and heart illnesses are driving a steady demand for diagnostic and therapeutic equipment.
- Competitiveness: Indian manufacturers are turning to low-cost production to sell equipment to Southeast Asia, Africa and Latin America, making India an “access-led innovator” in emerging global markets.
- Digital health integration: Augmenting physical hardware with artificial intelligence, IoT and telemedicine to enable remote patient monitoring, predictive diagnostics and digital healthcare delivery models.
- Scope for Import Substitution: It has also created great economic potential for local producers as they substitute high-tech imports and make the supply chain more resilient as domestic capacity grows.
- Affordability : Breakthroughs such handheld ultrasound probes, point-of-care testing kits, and portable ECG equipment – empower primary health centers and rural clinics to provide prompt care without costly infrastructure, democratising rural access.
Issues and Concerns
- High Import Dependence: The country remains vulnerable to global supply shocks, high-end equipment including MRI scanners, CT systems and advanced cancer devices still being imported.
- Most local production is still focused on basic consumables, disposables or final assembly, with important components and sub-assemblies still being imported from outside markets.
- Costs and Capital Constraints: Developing deep-tech medical devices is a capital-intensive process with extensive clinical validation cycles and complicated multi-stage testing which can be challenging for early-stage startups & MSMEs.
- Complex Regulatory Environment: The risk-based classification procedure, quality compliance criteria and duplication approvals from both national and state authorities could lengthen time to market.
- India has not yet issued complete norms, which has created a largely uncontrolled market of ₹1,500 crore.
- Skilled Talent Shortage: The shortage of qualified biomedical engineers, clinical trial managers and regulatory compliance professionals is impeding rapid scaling and technology innovation.
Governments Steps
- PLI Scheme for Medical Devices : Incentivising domestic manufacturing in radiation, imaging, anaesthesia, critical care and implants with an outlay of ₹3,420 crore (FY2022-23 to FY2026-27).
- Medical Devices Parks Scheme: To provide world-class common infrastructure and lower production costs through economies of scale. Ujjain, Kanchipuram and Greater Noida creating three parks with centre’s aid of ₹300 crore.
- Strengthening Medical Device Industry Scheme (2024) : With a ₹500-crore investment it promotes the manufacturing of crucial components, skill development, clinical investigations, common infrastructure and industry promotion, hence enhancing the broader MedTech ecosystem.
Conclusion
- India’s MedTech industry is transforming from a consumer-driven market to a self-sustaining innovation and manufacturing base.
- The vast local market, qualified labour, cost advantage and burgeoning healthcare infrastructure provide significant global possibilities.
- A coordinated ecosystem of government, industry, academia, hospitals and startups can help India go beyond assembly to indigenous innovation and globally competitive and cheap medical solutions and thereby advance Atmanirbhar Bharat and better healthcare results.
Source :BS
